Journal details
MOLECULAR DIAGNOSIS & THERAPY
ADIS INT LTD · ISSN 1177-1062 · eISSN 1179-2000
SCIEScopusMEDLINEPubMedPMC
Overview
MOLECULAR DIAGNOSIS & THERAPY. ISSN 1177-1062 · eISSN 1179-2000. published by ADIS INT LTD. New Zealand. Genetics & Heredity · Pharmacology & Pharmacy. impact factor 5.8 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 30 articles · 2025: 62 articles · 2024: 72 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR DIAGNOSIS & THERAPY?
The impact factor recorded for MOLECULAR DIAGNOSIS & THERAPY is 5.8 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR DIAGNOSIS & THERAPY?
MOLECULAR DIAGNOSIS & THERAPY is listed in CAS Zone 3.
Which databases index MOLECULAR DIAGNOSIS & THERAPY?
MOLECULAR DIAGNOSIS & THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.